Logo image of PYR

PYROGENESIS CANADA INC (PYR) Stock Fundamental Analysis

NASDAQ:PYR - CA74734T1049 - Common Stock

0.3799 USD
0 (0%)
Last: 11/15/2023, 8:00:02 PM
0.3499 USD
-0.03 (-7.9%)
After Hours: 11/15/2023, 8:00:02 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to PYR. PYR was compared to 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of PYR have multiple concerns. PYR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PYR had negative earnings in the past year.
PYR had a negative operating cash flow in the past year.
PYR had negative earnings in 4 of the past 5 years.
PYR had a negative operating cash flow in each of the past 5 years.
PYR Yearly Net Income VS EBIT VS OCF VS FCFPYR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -74.66%, PYR is doing worse than 95.06% of the companies in the same industry.
With a Return On Equity value of -245.07%, PYR is not doing good in the industry: 92.59% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -74.66%
ROE -245.07%
ROIC N/A
ROA(3y)-22.17%
ROA(5y)-50.37%
ROE(3y)-71.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PYR Yearly ROA, ROE, ROICPYR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 500 -500

1.3 Margins

PYR's Gross Margin of 42.71% is amongst the best of the industry. PYR outperforms 81.48% of its industry peers.
PYR's Gross Margin has been stable in the last couple of years.
PYR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.59%
GM growth 5Y-0.32%
PYR Yearly Profit, Operating, Gross MarginsPYR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 100 -100 200

More info and screens

1

2. Health

2.1 Basic Checks

PYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PYR has been increased compared to 1 year ago.
Compared to 1 year ago, PYR has a worse debt to assets ratio.
PYR Yearly Shares OutstandingPYR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
PYR Yearly Total Debt VS Total AssetsPYR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -3.90, we must say that PYR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.90, PYR is doing worse than 90.12% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that PYR is not too dependend on debt financing.
The Debt to Equity ratio of PYR (0.29) is better than 62.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z -3.9
ROIC/WACCN/A
WACC8.53%
PYR Yearly LT Debt VS Equity VS FCFPYR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.86 indicates that PYR may have some problems paying its short term obligations.
With a Current ratio value of 0.86, PYR is not doing good in the industry: 80.25% of the companies in the same industry are doing better.
PYR has a Quick Ratio of 0.86. This is a bad value and indicates that PYR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PYR (0.78) is worse than 79.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.78
PYR Yearly Current Assets VS Current LiabilitesPYR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.03% over the past year.
PYR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -45.10%.
PYR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.47% yearly.
EPS 1Y (TTM)31.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.67%
Revenue 1Y (TTM)-45.1%
Revenue growth 3Y58.11%
Revenue growth 5Y21.47%
Sales Q2Q%-48.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PYR Yearly Revenue VS EstimatesPYR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
PYR Yearly EPS VS EstimatesPYR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 -0.01 -0.02 -0.03 -0.04 -0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PYR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PYR Price Earnings VS Forward Price EarningsPYR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PYR Per share dataPYR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PYR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PYROGENESIS CANADA INC

NASDAQ:PYR (11/15/2023, 8:00:02 PM)

After market: 0.3499 -0.03 (-7.9%)

0.3799

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-10 2023-11-10/bmo
Earnings (Next)03-28 2024-03-28/bmo
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.96M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.37
P/FCF N/A
P/OCF N/A
P/B 8.29
P/tB 13.7
EV/EBITDA N/A
EPS(TTM)-0.12
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.06
BVpS0.05
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.66%
ROE -245.07%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.71%
FCFM N/A
ROA(3y)-22.17%
ROA(5y)-50.37%
ROE(3y)-71.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.59%
GM growth 5Y-0.32%
F-Score2
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.85%
Cap/Sales 4.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.78
Altman-Z -3.9
F-Score2
WACC8.53%
ROIC/WACCN/A
Cap/Depr(3y)107.34%
Cap/Depr(5y)207.81%
Cap/Sales(3y)4.62%
Cap/Sales(5y)12.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.1%
Revenue growth 3Y58.11%
Revenue growth 5Y21.47%
Sales Q2Q%-48.02%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y45.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.11%
OCF growth 3YN/A
OCF growth 5YN/A